<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Price Info, Side Effects, Dosage, Compare Cost, Pros &#38; Cons, Reviews by Patients and Customers. &#187; votrient dosage</title>
	<atom:link href="http://www.alldrugreviews.com/tag/votrient-dosage/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.alldrugreviews.com</link>
	<description>Online Drugs and Medicine Reviews by Patients</description>
	<lastBuildDate>Fri, 10 Sep 2010 05:44:37 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Votrient</title>
		<link>http://www.alldrugreviews.com/2009/12/votrient/</link>
		<comments>http://www.alldrugreviews.com/2009/12/votrient/#comments</comments>
		<pubDate>Thu, 24 Dec 2009 11:17:58 +0000</pubDate>
		<dc:creator>Reviewer</dc:creator>
				<category><![CDATA[votrient dosage]]></category>
		<category><![CDATA[votrient reviews]]></category>
		<category><![CDATA[votrient side effects]]></category>
		<category><![CDATA[z-AZ Drugs]]></category>

		<guid isPermaLink="false">http://www.alldrugreviews.com/?p=236</guid>
		<description><![CDATA[Votrient (pazopanib) is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. Votrient is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body. Votrient is used to treat advanced renal cell carcinoma (kidney cancer). Votrient may also be used for other [...]]]></description>
		<wfw:commentRss>http://www.alldrugreviews.com/2009/12/votrient/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
